US FDA issues warning letter to Lupin's Tarapur unit

The United States Food and Drug Administration (US FDA) has issued a warning letter to Lupin's Tarapur, Maharashtra facility, the company said in a stock exchange filing on Thursday. Lupin in a statement said it does not believe that the warning letter will have an impact or disruption of supplies or the existing revenues from operations of this facility.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news